IL-1Ra and CCL5, but not IL-10, are promising targets for treating SMA astrocyte-driven pathology https://www.biorxiv.org/content/10.1101/2023.08.10.552842v1?med=mas
IL-1Ra and CCL5, but not IL-10, are promising targets for treating SMA astrocyte-driven pathology https://www.biorxiv.org/content/10.1101/2023.08.10.552842v1?med=mas